Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ALL patients IN THE study will BE treated with ocrelizumab----1件: 13 💬
2Continued ocrelizumab----1件: 13 💬
3Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab----1件: 13 💬
4Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
5Observation OF ocrelizumab AS treatment IN rrms patients----1件: 13 💬
6Ocrelizumab1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬4件: 11, 13, 46, 49 💬
7Ocrelizumab / rhumab 2h71件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
8Ocrelizumab 300 MG1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
9Ocrelizumab 300MG1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
10Ocrelizumab 300MG/10 ML1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
11Ocrelizumab 300MG/10ML1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
12Ocrelizumab 500MG1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
13Ocrelizumab 600 MG1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
14Ocrelizumab AT home1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
15Ocrelizumab dose 11件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
16Ocrelizumab dose 2 and dose 31件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
17Ocrelizumab IV1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
18Ocrelizumab SC1件: Ocrelizumab (Ocrelizumab)1件: Ocrelizumab (Ocrelizumab, Ocrelizumab) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
19Ocrelizumabu 200MG----1件: 46 💬
20Ocrelizumabu 50MG----1件: 46 💬
21Perfusion OF treatment ocrelizumab----1件: 13 💬
22Short-course ocrelizumab----1件: 13 💬